
Headquartered in North Chicago, Illinois, Abbott Laboratories (ABT) discovers, develops, manufactures, and sells health care products in the United States and internationally. The company operates in four segments: Established Pharmaceutical Products; Diagnostic Products; Nutritional Products; and Medical Devices. It has a market capitalization of $185.09 billion.
This month, ABT announced resuming baby formula production at its Sturgis, Michigan facility. The Sturgis plant was shut down in February over contamination issues. The production restarted on June 1 after meeting initial requirements agreed to with the U.S. Food and Drug Administration (FDA) as a part of the consent decree entered on May 16.